Fund Holdings — Madison Avenue Partners, LP

Total Portfolio Value:
$619.86M
Total Bought:
$158.58M
Total Sold:
$229.66M
Net Transaction:
-$71.09M
Notable People:
Christopher Adien Carroll
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Graham Holdings CompanyCL B(GHC)209,401210,717+1,316$145.85M$161.76M26.10%+$15.91M
SharkNinja, Inc.(SN)3,681,9141,807,237-1,874,677$188.40M$112.57M18.16%-$75.83M
Theravance Biopharma Inc7,012,2267,012,2260$78.82M$62.90M10.15%-$15.92M
John Wiley & Sons, Inc.CL A(WLY)01,366,771+1,366,771$0$52.11M8.41%+$52.11M
Hess Corp300,270300,2700$43.29M$45.83M7.39%+$2.55M
Stagwell Inc.CL A(STGW)7,147,6627,147,6620$47.39M$44.46M7.17%-$2.93M
Globus Medical, Inc.CL A(GMED)0703,276+703,276$0$37.72M6.09%+$37.72M
Nelnet, Inc.CL A(NNI)0290,213+290,213$0$27.47M4.43%+$27.47M
Mechanics Bancorp(MCHB)0905,022+905,022$0$13.62M2.20%+$13.62M
2seventy Bio Inc1,754,7882,433,222+678,434$7.49M$13.02M2.10%+$5.52M
Ovid Therapeutics Inc.(OVID)3,648,5093,648,5090$11.75M$11.13M1.80%-$620.2K
Orion Properties Inc.(ONL)2,989,5652,618,529-371,036$17.10M$9.19M1.48%-$7.91M
Franklin Street Properties Corp.(FSP)3,291,4433,291,4430$8.43M$7.47M1.21%-$954.5K
Merrimack Pharmaceuticals Inc553,085387,221-165,864$7.42M$5.72M0.92%-$1.70M
Gossamer Bio, Inc.(GOSS)5,054,4724,140,773-913,699$4.61M$4.89M0.79%+$273.9K
The Central and Eastern Europe Fund, Inc.(CEE)273,957422,823+148,866$2.67M$4.03M0.65%+$1.35M
Indivior Plc72,255162,895+90,640$1.10M$3.49M0.56%+$2.39M
Atmus Filtration Technologies Inc.(ATMU)076,732+76,732$0$2.47M0.40%+$2.47M
Cartesian Therapeutics Inc582,6030-582,603$401.6K$0—-$401.6K
G-III Apparel Group, Ltd.(GIII)1,323,1100-1,323,110$44.96M$0—-$44.96M
Integra LifeSciences Holdings Corporation(IART)1,042,1560-1,042,156$45.39M$0—-$45.39M
Mirati Therapeutics Inc417,4270-417,427$24.52M$0—-$24.52M
Safeguard Scientifics, Inc.(SFES)264,0490-264,049$207.1K$0—-$207.1K
Vestis Corporation(VSTS)1,346,9800-1,346,980$28.48M$0—-$28.48M
Page 1 of 1
Madison Avenue Partners, LP — 13F Holdings — Q1 2024 | TickerTrail